Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Shares Outstanding (Diluted Average): 2013-2024

Historic Shares Outstanding (Diluted Average) for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $126.1 million.

  • Surgery Partners' Shares Outstanding (Diluted Average) rose 81.95% to $127.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $127.2 million, marking a year-over-year increase of 81.95%. This contributed to the annual value of $126.1 million for FY2024, which is 40.52% up from last year.
  • Per Surgery Partners' latest filing, its Shares Outstanding (Diluted Average) stood at $126.1 million for FY2024, which was up 40.52% from $125.6 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Shares Outstanding (Diluted Average) registered a high of $126.1 million during FY2024, and its lowest value of $48.8 million during FY2020.
  • In the last 5 years, Surgery Partners' Shares Outstanding (Diluted Average) had a median value of $92.0 million in 2022 and averaged $93.0 million.
  • Per our database at Business Quant, Surgery Partners' Shares Outstanding (Diluted Average) surged by 4848.9% in 2021 and then surged by 40.52% in 2024.
  • Over the past 5 years, Surgery Partners' Shares Outstanding (Diluted Average) (Annual) stood at $48.8 million in 2020, then skyrocketed by 48.49% to $72.4 million in 2021, then rose by 26.96% to $92.0 million in 2022, then skyrocketed by 36.61% to $125.6 million in 2023, then grew by 0.41% to $126.1 million in 2024.
  • Its Shares Outstanding (Diluted Average) stands at $126.1 million for FY2024, versus $125.6 million for FY2023 and $92.0 million for FY2022.